These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 23870722)

  • 21. The impact of non-surgical periodontal treatment on serum levels of long chain-polyunsaturated fatty acids: a pilot randomized clinical trial.
    Martinez GL; Koury JC; Brito F; Fischer RG; Gustafsson A; Figueredo CM
    J Periodontal Res; 2014 Apr; 49(2):268-74. PubMed ID: 23721647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for Psychosis.
    Amminger GP; Nelson B; Markulev C; Yuen HP; Schäfer MR; Berger M; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EYH; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Thompson A; Yung AR; McGorry PD
    Biol Psychiatry; 2020 Feb; 87(3):243-252. PubMed ID: 31690495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of fish oil (n-3 polyunsaturated fatty acids) on plasma lipids, lipoproteins and inflammatory markers in HIV-infected patients treated with antiretroviral therapy: a randomized, double-blind, placebo-controlled study.
    Thusgaard M; Christensen JH; Mørn B; Andersen TS; Vige R; Arildsen H; Schmidt EB; Nielsen H
    Scand J Infect Dis; 2009; 41(10):760-6. PubMed ID: 19685375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences between Japan and Taiwan in the treatment of pregnant women with depressive symptoms by omega-3 fatty acids: An open-label pilot study.
    Nishi D; Su KP; Usuda K; Chang JP; Chiang YJ; Guu TW; Hamazaki K; Nakaya N; Sone T; Hashimoto K; Hamazaki T; Matsuoka YJ
    Nutr Neurosci; 2019 Jan; 22(1):63-71. PubMed ID: 28752805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction in triglyceride level with N-3 polyunsaturated fatty acids in HIV-infected patients taking potent antiretroviral therapy: a randomized prospective study.
    De Truchis P; Kirstetter M; Perier A; Meunier C; Zucman D; Force G; Doll J; Katlama C; Rozenbaum W; Masson H; Gardette J; Melchior JC
    J Acquir Immune Defic Syndr; 2007 Mar; 44(3):278-85. PubMed ID: 17179770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of supplementation with long-chain ω-3 polyunsaturated fatty acids on behavior and cognition in children with attention deficit/hyperactivity disorder (ADHD): a randomized placebo-controlled intervention trial.
    Widenhorn-Müller K; Schwanda S; Scholz E; Spitzer M; Bode H
    Prostaglandins Leukot Essent Fatty Acids; 2014; 91(1-2):49-60. PubMed ID: 24958525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nutrient supplementation with polyunsaturated fatty acids and micronutrients in rheumatoid arthritis: clinical and biochemical effects.
    Remans PH; Sont JK; Wagenaar LW; Wouters-Wesseling W; Zuijderduin WM; Jongma A; Breedveld FC; Van Laar JM
    Eur J Clin Nutr; 2004 Jun; 58(6):839-45. PubMed ID: 15164103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of omega-3 fatty acids in the treatment of borderline personality disorder: a study of the association with valproic acid.
    Bellino S; Bozzatello P; Rocca G; Bogetto F
    J Psychopharmacol; 2014 Feb; 28(2):125-32. PubMed ID: 24196948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Omega-3 Polyunsaturated Fatty Acid Supplementation on Bone Turnover in Older Women.
    Dong H; Hutchins-Wiese H; Kleppinger A; Annis K; Liva E; Lammi-Keefe C; Durham H; Feinn R; Kenny AM
    Int J Vitam Nutr Res; 2014; 84(3-4):124-32. PubMed ID: 26098476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frontal delta power associated with negative symptoms in ultra-high risk individuals who transitioned to psychosis.
    Lavoie S; Schäfer MR; Whitford TJ; Benninger F; Feucht M; Klier CM; Yuen HP; Pantelis C; McGorry PD; Amminger GP
    Schizophr Res; 2012 Jul; 138(2-3):206-11. PubMed ID: 22520856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Omega-3 treatment of childhood depression: a controlled, double-blind pilot study.
    Nemets H; Nemets B; Apter A; Bracha Z; Belmaker RH
    Am J Psychiatry; 2006 Jun; 163(6):1098-100. PubMed ID: 16741212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation.
    da Silva TM; Munhoz RP; Alvarez C; Naliwaiko K; Kiss A; Andreatini R; Ferraz AC
    J Affect Disord; 2008 Dec; 111(2-3):351-9. PubMed ID: 18485485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The older people, omega-3, and cognitive health (EPOCH) trial design and methodology: a randomised, double-blind, controlled trial investigating the effect of long-chain omega-3 fatty acids on cognitive ageing and wellbeing in cognitively healthy older adults.
    Danthiir V; Burns NR; Nettelbeck T; Wilson C; Wittert G
    Nutr J; 2011 Oct; 10():117. PubMed ID: 22011460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized placebo-controlled trial of an omega-3 fatty acid and vitamins E+C in schizophrenia.
    Bentsen H; Osnes K; Refsum H; Solberg DK; Bøhmer T
    Transl Psychiatry; 2013 Dec; 3(12):e335. PubMed ID: 24346133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Omega-3 Fatty Acids, Depressive Symptoms, and Cognitive Performance in Patients With Coronary Artery Disease: Analyses From a Randomized, Double-Blind, Placebo-Controlled Trial.
    Mazereeuw G; Herrmann N; Oh PI; Ma DW; Wang CT; Kiss A; Lanctôt KL
    J Clin Psychopharmacol; 2016 Oct; 36(5):436-44. PubMed ID: 27529771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mentalization-based treatment in groups for adolescents with borderline personality disorder (BPD) or subthreshold BPD versus treatment as usual (M-GAB): study protocol for a randomized controlled trial.
    Beck E; Bo S; Gondan M; Poulsen S; Pedersen L; Pedersen J; Simonsen E
    Trials; 2016 Jul; 17(1):314. PubMed ID: 27405522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study.
    Chiu CC; Su KP; Cheng TC; Liu HC; Chang CJ; Dewey ME; Stewart R; Huang SY
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1538-44. PubMed ID: 18573585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Omega-3 polyunsaturated fatty acids and psychological intervention for workers with mild to moderate depression: A double-blind randomized controlled trial.
    Tayama J; Ogawa S; Nakaya N; Sone T; Hamaguchi T; Takeoka A; Hamazaki K; Okamura H; Yajima J; Kobayashi M; Hayashida M; Shirabe S
    J Affect Disord; 2019 Feb; 245():364-370. PubMed ID: 30423463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.
    Young GS; Conquer JA; Thomas R
    Reprod Nutr Dev; 2005; 45(5):549-58. PubMed ID: 16188207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No effect of n-3 fatty acids on high-sensitivity C-reactive protein after myocardial infarction: the Alpha Omega Trial.
    Hoogeveen EK; Geleijnse JM; Kromhout D; Giltay EJ
    Eur J Prev Cardiol; 2014 Nov; 21(11):1429-36. PubMed ID: 23774275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.